Pro-ficiency Acquires Fugitive Labs

July 12, 2022

Pro-ficiency has acquired all life-sciences intellectual property and the associated team of Fugitive Labs, bringing Fugitive's product development capabilities and team (led by Erik Guffrey) into Pro-ficiency's platform. The deal expands Pro-ficiency's product development capacity for clinical-trials simulation and performance-management products and is the company's first acquisition since being funded by NovaQuest Private Equity in 2021.

Buyers
Pro-ficiency
Targets
Fugitive Labs
Platforms
Pro-ficiency
Location
North Carolina, United States
Transaction Type
Addon

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.